Session » Patient Outcomes, Preferences, and Attitudes Poster II

Date: Monday, November 6, 2017

Time: 9:00AM-11:00AM

Meeting: 2017 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 1257

A Scoping Review of Contextual Factors of Patient Decision Aids in Osteoarthritis

9:00AM-11:00AM: Abstract Number: 1240

Active Disease Is Associated with Dependency in Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 1244

Are Chinese-American Rheumatology Patients Who Use Traditional Chinese Medicine Less Adherent to Prescribed Western Medications?

9:00AM-11:00AM: Abstract Number: 1251

Chinese Patient Reported Index with Rheumatoid Arthritis (CPRI-RA): Reliability, Validity and Agreement with DAS28 and HAQ

9:00AM-11:00AM: Abstract Number: 1243

Clarifying Patient-Determined Barriers in Living with Systemic Lupus Erythematosus Treatment: A Qualitative Ethnographic Approach

9:00AM-11:00AM: Abstract Number: 1247

Coexisting Fibromyalgia in Patients with Rheumatoid Arthritis Worsens Scores for Pain, Physical Function and Depression

9:00AM-11:00AM: Abstract Number: 1258

Divided By a Common Language: Challenges in Physician-Patient Communication Limit Patient Understanding and Support in Systemic Sclerosis with Interstitial Lung Disease (SSc-ILD)

9:00AM-11:00AM: Abstract Number: 1254

Eliciting the Research Priorities of Parents and Children with Juvenile Myositis

9:00AM-11:00AM: Abstract Number: 1233

Establishing and Maintaining a Volunteer Charity Rheumatology Clinic: One Clinic’s Experience

9:00AM-11:00AM: Abstract Number: 1248

Evaluation of Validated Patient Reported Outcome Measures to Assess Sensitivity to Change in Patients with Systemic Sclerosis and Gastroesophageal Reflux Disease —a Scleroderma Clinical Trials Consortium Collaborative Project

9:00AM-11:00AM: Abstract Number: 1237

Group Strength Training in Rheumatology Patients: Results of an Exercise Survey

9:00AM-11:00AM: Abstract Number: 1234

How Machine Learning Statistics Can Change the Game of Data Analysis in Rheumatology: The Example a Study with 170 Patients with Rheumatoid Arthritis (ra) or Axial Spondyloarthritis (axspa)

9:00AM-11:00AM: Abstract Number: 1242

Impact of Social Support and Illness Perception on the Transition of Pediatric SLE Patients to Adult Care

9:00AM-11:00AM: Abstract Number: 1260

Lupus Diagnosis: Process and Patient Experience

9:00AM-11:00AM: Abstract Number: 1250

Outcomes in Real-World Patients with Early Aggressive Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1246

Patient Preferences Associated with the Use of Treatments for Psoriatic Arthritis: Results of a Conjoint Analysis

9:00AM-11:00AM: Abstract Number: 1253

Patient Reported Outcomes Explain the Lack of Agreement between Physician and Patient Perceived Remission in Early Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1235

Perceived Stress and Fatigue in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1259

Perspectives of Young People with Juvenile Idiopathic Arthritis, Their Caregivers, and Health Care Providers on Transition to Adult Care: Informing Development of a Transition Toolkit

9:00AM-11:00AM: Abstract Number: 1252

Real-World Oral Methotrexate Adherence Measured Electronically in Patients with Established Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1263

Relevance and Utility of Patient Reported Outcomes Measurement Information System (PROMIS®) Instruments in SLE: A Qualitative Study

9:00AM-11:00AM: Abstract Number: 1264

Responsiveness of Patient Reported Outcomes Measurement Information System (PROMIS®) Computerized Adaptive Tests (CATs) in Systemic Lupus Erythematosus (SLE)

9:00AM-11:00AM: Abstract Number: 1231

Scope and Consistency of Adherence Related Outcomes in Randomized Controlled Trials of Interventions for Improving Medication Adherence

9:00AM-11:00AM: Abstract Number: 1262

Stability of Two Short Medication Adherence Questionnaires over Time for Follow-up in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1238

The Development of the Lupus Foundation of America—Rapid Evaluation of Activity in Lupus (LFA-REAL™) Patient-Reported Outcome (PRO) to Evaluate Lupus Disease Activity

9:00AM-11:00AM: Abstract Number: 1261

The Effects of Disease Burden, Helplessness, and Pain on Depressive Symptoms in Rheumatoid Arthritis and Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1236

The Influence of Testimonials on Patient Decision-Making

9:00AM-11:00AM: Abstract Number: 1232

The Perceived Impact of Recent-Onset Psoriatic Arthritis Is Different between Genders: A Spanish Multicenter Experience

9:00AM-11:00AM: Abstract Number: 1245

Transition in Work Status and Quality of Life in People with Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 1241

Understanding Differences in Patient Definitions of RA Flares Using Omeract Core Domains

9:00AM-11:00AM: Abstract Number: 1256

Uptake of Influenza and Pneumococcal Vaccination in Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 1255

Using PROs to Guide Patient-Centered Conversations and Care in Inflammatory Arthritis: The Clinician Perspective

9:00AM-11:00AM: Abstract Number: 1239

Web Based Educational Intervention to Improve Cardiovascular Disease Knowledge Among RA Patients

9:00AM-11:00AM: Abstract Number: 1249

What Factors Predict Good Patient Experiences of Switching from Reference Etanercept (EnbrelTM) to an Etanercept Biosimilar (BenepaliTM) in a South West London General Hospital?

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].